Related Experiment Videos
Cytogenetics and experimental models of sarcomas
1University of Nebraska Medical Center, Omaha, USA.
Current Opinion in Oncology
|July 1, 1995
Summary
Cytogenetic abnormalities, including translocations and ring chromosomes, aid in diagnosing challenging bone and soft tissue sarcomas. Research into novel fusion genes and their clinical impact is ongoing.
Area of Science:
- Oncology
- Genetics
- Pathology
Background:
- Bone and soft tissue sarcomas present significant diagnostic challenges.
- Cytogenetic abnormalities offer valuable insights into tumor development (histogenesis).
Purpose of the Study:
- To summarize the role of cytogenetic abnormalities in sarcoma diagnosis and histogenesis.
- To highlight the significance of translocations, fusion genes, and ring chromosomes in sarcomas.
Main Methods:
- Review of cytogenetic findings in bone and soft tissue sarcomas.
- Detection methods include reverse transcriptase polymerase chain reaction (RT-PCR) for transcripts.
- Advanced techniques like fluorescence in situ hybridization (FISH) and comparative genomic hybridization (CGH) for chromosomal analysis.
Main Results:
- Translocations creating chimeric fusion genes are common, often acting as oncogenic transcription factors.
- Variant fusion genes occur less frequently (e.g., in Ewing's sarcoma) with unknown clinical significance.
- Supernumerary ring chromosomes are frequent in intermediate/borderline sarcomas, with FISH/CGH revealing their composition and associated gene amplifications.
Conclusions:
- Cytogenetic analysis is crucial for understanding sarcoma complexity and improving diagnosis.
- Further research is needed to elucidate the clinical implications of variant fusion genes.
- Ring chromosomes and gene amplifications provide further diagnostic and potentially therapeutic targets.